Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

4789 Pages (Click to Jump) V  « < 378 379 380 381 382 383 384 > »    
 
  
Reply to this topic

CUV, CLINUVEL PHARMACEUTICALS LIMITED
Dr Wally
post Posted: May 1 2019, 12:28 AM
  Quote Post


Posts: 543
Thanks: 572


“Should you invest?

Whilst I think CLINUVEL is an exciting company and SCENESSE is a quality product, I wouldn’t be a buyer of its shares at the current level for valuation reasons.

As strong as its growth has been this year, I’m not convinced it justifies its market capitalisation of approximately $1.15 billion.

One ASX Stock For An Estimated $US22 Billion Marijuana Market

A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

And make no mistake – it is coming. To the tune of an estimated $US22 billion.”


******** Uummmm hello! CLINUVEL has the KEY to profiting off of the coming photo protection boom. Clinical research has also shown the drug to be of benefit in a number of important areas of human health that could turn out to be just as remarkable and lucrative.

Make no mistake, this wholesome Australian company hasn’t even started it’s growth phase yet and these figures will be dwarfed within a few years of the all important FDA approval being attained. Underestimate the sleeping giant Clinuvel at your own peril. ********



--------------------
The truth is, sunlight is just like water. Both are deadly dangerous if you get the dosage wrong but both are absolutely essential to life on earth. 😎

Said 'Thanks' for this post: Clinhope  
 
seeva222
post Posted: Apr 30 2019, 11:47 PM
  Quote Post


Posts: 1,400
Thanks: 1525


In Reply To: macgyver's post @ Apr 30 2019, 07:28 PM

4x increase in production/manufacturing costs? I've been trying to get my Mom to buy on the dip, maybe this will work.

 
Dr Wally
post Posted: Apr 30 2019, 09:36 PM
  Quote Post


Posts: 543
Thanks: 572


In Reply To: macgyver's post @ Apr 30 2019, 07:28 PM


Nice detective work Sherlock, I mean mcgyver. 🤓

The signs couldn’t be any more positive could they. If I had EPP and lived in the states I’d be pretty freakin excited. I new lease on life is surely just a few months away. 😎






--------------------
The truth is, sunlight is just like water. Both are deadly dangerous if you get the dosage wrong but both are absolutely essential to life on earth. 😎

Said 'Thanks' for this post: macgyver  
 
macgyver
post Posted: Apr 30 2019, 07:28 PM
  Quote Post


Posts: 644
Thanks: 576


In Reply To: royco's post @ Apr 30 2019, 04:28 PM

$1.8 mil production/manufacturing costs estimated for the next quarter compared with $1.9 mil total for the last 3 quarters. For 4Q 2018 it was $445,000. That’s significant even allowing for a possible 40% increase in European operations, and a clue to the progression of the NDA...

Approx. $700k earmarked for U.S operations?

 
juxtaposer
post Posted: Apr 30 2019, 07:13 PM
  Quote Post


Posts: 148
Thanks: 221


In Reply To: odi01's post @ Apr 30 2019, 06:21 PM

Ha!

 
waz
post Posted: Apr 30 2019, 06:48 PM
  Quote Post


Posts: 164
Thanks: 519


In Reply To: totallysour's post @ Apr 30 2019, 03:31 PM

A 40% pcp increase leads to 2Q19 revenue of $14.5m & PBT $10.5m after circa $4m predicted costs
Attached image(s)
Attached Image

 



Said 'Thanks' for this post: royco  PunkassDerm  
 

sentifi.com

Share Cafe Sentifi Top themes and market attention on:


odi01
post Posted: Apr 30 2019, 06:21 PM
  Quote Post


Posts: 658
Thanks: 1475


https://www.fool.com.au/2019/04/30/clinuvel...y-sales-growth/


Said 'Thanks' for this post: royco  PunkassDerm  
 
royco
post Posted: Apr 30 2019, 04:28 PM
  Quote Post


Posts: 2,917
Thanks: 4534


In Reply To: totallysour's post @ Apr 30 2019, 03:31 PM

Great result
Veritas in numeris
Prediction cited 1.8 mln manufacturing costs for the current quarter.
Now get the USA on board and we increase growth again.






--------------------
Ἀρτεμίσιον

Said 'Thanks' for this post: macgyver  
 
totallysour
post Posted: Apr 30 2019, 03:31 PM
  Quote Post


Posts: 129
Thanks: 408


Receipts for those keeping track:

1Q19 5,898,000
4Q18 2,608,000
3Q18 10,705,000
2Q18 10,388,000
1Q18 3,480,000
4Q17 4,199,000
3Q17 5,638,000
2Q17 6,247,000
1Q17 1,597,000
4Q16 4,352,000
3Q16 5,728,000
**2Q16 1,235,000
1Q16 821,000
4Q15 453,000
3Q15 1,139,000
2Q15 540,000
1Q15 1,012,000
4Q14 376,000
3Q14 619,000
2Q14 923,000
1Q14 197,000
4Q13 587,000
3Q13 188,000
2Q13 455,000
1Q13 275,000
4Q12 863,000

Prev 12 mths - 29.599m
FY17/18 - 23.705m
FY16/17 - 17.924m
FY15/16 - 3.648m
FY14/15 - 2.547m
FY13/14 - 1.985m

**First commercial sale June 2016


Said 'Thanks' for this post: NewToCli  royco  blackm3  Ray Cokes  Dr Wally  Alaaf  Clinhope  odi01  waz  johnnytech  PunkassDerm  hibchibbler  
 
Justinian
post Posted: Apr 30 2019, 02:49 PM
  Quote Post


Posts: 269
Thanks: 388


In Reply To: LevelHeaded2000's post @ Apr 30 2019, 02:28 PM

I've never followed specific stocks too closely besides this one. Does this basically just go away once there is higher volume and shorting can't drive the price as much? Are other ASX300 stocks impacted by this too?

 
 


4789 Pages (Click to Jump) V  « < 378 379 380 381 382 383 384 > » 

Back To Top Of Page
Reply to this topic


You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.


TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING